share_log
Breakings ·  Jun 5 04:34
Kezar Life Sciences is eligible to receive an additional 180 days or until November 25th to meet the Nasdaq minimum bid price requirement.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment